Syphilis rates have increased drastically in recent years. Learn how others are addressing these rising rates and the techniques clinicians are using to detect, treat, and prevent infections.
In advance of the Strategies for an HIV Cure meeting, AVAC is hosting a foundational training for lay audiences interested in building their knowledge of HIV cure research. Through interactive sessions led by leading experts in the field, the meeting will provide attendees the ability to understand and translate basic science information.
The program will feature: Janet Siliciano, Deborah Persaud, Steven Deeks, Rebecca Lynch and David Margolis.
A Legacy of Impact: The power and reach of AVAC’s Advocacy Fellows
For more than a decade, alumni from AVAC’s Advocacy Fellows program have been expanding the reach of HIV prevention and advancing global health equity around the world. They are influencing research and strengthening healthcare to become more effective and equitable across the continent of Africa and beyond. A review of their career achievements shows how this unique program is contributing to the strength of a generation of leaders, and how their cumulative efforts are shaping the HIV response for the better.
Founded in 2009, the Advocacy Fellows program offers technical and financial support to individuals living in areas where HIV incidence is high, with a particular focus on African countries. The program invests in a select group of advocates who have an interest in improving the HIV response in their communities. The program pairs individuals with a community-based host organization where they pursue an 18-month advocacy project. Both the individual fellow and the host organization develop expertise and advocacy skills, gain access to influential stakeholders and networks, and receive intensive mentoring.
Nearly 100 advocates working with 70+ partner organizations across 15 countries have participated in the program. In that time, Fellows have:
Founded or leads more than 85 influential organizations, coalitions and campaigns.
Changed more than 84 national policies in support of HIV prevention or greater equity in public health.
Won significant funding* increases for more than 83 different high-priority prevention programs and projects.
Gained approval for over 35 innovative programs (including implementation, service delivery or community projects) and research projects.
Led nearly 200 high-impact efforts** to create an enabling environment for HIV prevention such as rallies, media placements, and research literacy initiatives.
Served on at least 150 high-level decision-making bodies, affecting policies, programs and funding at national and global levels.
A look at the careers of three alumni – Kenya’s Grace Kamau, Uganda’s Kenneth Mwehonge and South Africa’s Yvette Raphael – exemplifies the importance of this program in preparing future leaders, and showcases the extensive influence that alumni Fellows have on public health.
Grace Kamau joined the 2011 Fellows program with experience as a peer-to-peer educator for a sex worker advocacy organization, the Bar Hostess Empowerment and Support Programme (BHSP). She describes herself at the time as shy, uncertain of how and when to speak her mind. “I didn’t even apply for a conference scholarship because I was intimidated to travel”. As she worked on her project— raising awareness of PrEP and microbicides research among a sex worker community in Kenya, and engaging with policy makers to support the provision of PrEP to sex workers— elements of the program’s mentoring brought a seismic shift in her advocacy. “The Fellowship builds the whole person, far beyond expertise in HIV prevention, I came out a changed person.” A host of skills came together: mastering a two minute speech in case of encountering a key official in a hall, making quick follow up a standard practice, retaining command of the facts, understanding HIV science and policy trends. “Ever since I came out of the Fellows program, I have stood out. I pinpoint what needs to be said and to whom. I understand the power of my voice to speak out for sex worker rights and welfare. That confidence was built during my fellowship, and I use it to advance a movement.”
Grace’s advocacy has contributed to more than 175,000 sex workers in five countries receiving access to HIV services through the Hands Off Project, which she chairs. Her advocacy has also given voice and visibility to sex workers from 35 African countries on the need for decriminalization, access to care and other anti-stigma work in her current role as Regional Coordinator of the Africa Sex Workers Alliance (ASWA).
Kenneth Mwehonge grew up in a region of Uganda burdened with some of the highest rates of HIV found anywhere in the world. He saw one sister die, unable to get treatment and another finally gain access to life-saving drugs after living with HIV for many years. In 2014, he applied for a fellowship, work with HEPS-Uganda as his host organization. At the tine, he had only local level experience in grassroots organizing and a desire to fight for broader access to treatment. “My Fellowship with AVAC was the turning point in my career.” Kenneth said his exposure to the alumni network, introductions to decision-makers, education about HIV prevention and the research process, and AVAC’s mentoring boosted his confidence and taught him the value of mashalling evidence, working with data, and tracking progress closely. “When the fellowship began I was sometimes quite intimidated to talk to leaders, but overtime that wasn’t true anymore.” By the end of his project, Kenneth had profoundly impacted the HIV response in Uganda, designing and promoting a plan for universal viral load monitoring that was embraced by both PEPFAR and the Uganda government. His leadership and advocacy continued to grow.
Today, Kenneth is the executive director of HEPS, the organization that once hosted him as a Fellow, and it has grown into one of the most trusted civil society institutions in the country. Kenneth is also the coordinator of the Uganda Coalition for Access to Essential Medicines. He devotes significant time to mentoring emerging advocates. “It does take a lot of time, but there is so much work to be done and it is so important to see young people with fresh thinking taking the work across the finish line.” Kenneth’s leadership is also prized at the international level; he currently serves as a member of the UNAIDS Global HIV Prevention Coalition and the lead for coordinating the 2025 roadmap for prevention in Uganda and Tanzania.
“For the first time, we have options—PrEP, the ring, and cabotegravir as an injection. But advocates from my hometown, where [HIV] prevalence is 17%, don’t even know these options exist! In the years ahead I will be working to see every proven option for HIV prevention is scaled up and rolled out.”
A veteran human rights activist, Yvette Raphael joined the AVAC Advocacy Fellowship cohort of 2014, with the Centre for Communication Impact (CCI) as her host organization. As a woman living with HIV, she wanted to develop a program to mobilize young women to fight for HIV prevention. She said the fellowship taught her how to implement advocacy, create a process, and be accountable to a grant. She emerged from the program with a laser focus and has since become one of the most prominent advocates for HIV prevention on the national and global stage. To name a few of her roles: Yvette is the Executive Director of South Africa’s Advocacy for Prevention of HIV and AIDS (APHA), an organization she co-founded with two other Fellow alumni – Ntando and Brian Kanyemba. She also serves on the South Africa National AIDS Commission. She was the keynote speaker at the 2023 Conference on Retroviruses and Opportunistic Infections. In the Journal of the International AIDS Society, Yvette recently co-authored Antibodies for HIV prevention: the path forward with world renowned scientists, issuing a call to action for a research agenda focused on ensuring equitable access.
She co-founded the African Women’s Prevention Accountability Board, which engages industry, research and government on ongoing and future research and is leading efforts to advance The HIV Prevention Choice Manifesto. She has helped to shape numerous programs and campaigns aimed at reaching vulnerable populations with HIV prevention and she mentors young advocates.
“The Fellows program took a chance with an unpolished, street smart activist and turned me into a boardroom eloquent and knowledgeable advocate. It was mentorship , contacts, support from the team, and solidarity with other fellows. I look down the road and I see there’s a chance to end this epidemic, but greed and power hoarding will derail all this, without advocates who are prepared and committed. I will be among them, with young advocates I am mentoring now, and so many fellow alumni by my side.”
For a comprehensive understanding of the impact of the Fellows program in its first decade, please see the AVAC Advocacy Fellows Program Evaluation, conducted in 2020.
Significant funding*- This data comes from advocacy that won funding increases from PEPFAR, Global Fund, philanthropy, bilateral government entities, and private industry for programs with extensive reach and impact, such as PrEP for AGYW and Community-led monitoring.
High-impact efforts**- This data reflects initiatives that were covered by the media, media placements in national press, social media campaigns that went viral.
Advancing Choice in HIV Prevention
In recent weeks, important new resources for advancing choice in HIV prevention have been announced. Don’t miss these highlights from the field. They point to an HIV response in transition, and help to define the role advocacy must play. As policy, practice and budgets strive to keep up with advances in research, advocacy around choice becomes a cross-cutting priority—so that the promise of new options in HIV prevention won’t be squandered in siloed programs, or by poorly-planned supply chains, or because of disconnected policy decisions. People have diverse needs and face complex challenges; ending HIV depends on finding the option that works best for each individual.
The Choice Manifesto
The African Women’s HIV Prevention Community Accounability Board (AWPCAB) launched the HIV Prevention Choice Manifesto, calling for increased political and financial support to ensure every proven method of HIV prevention is integrated into the HIV response, so that all women who need prevention will have access to the options that will make prevention possible for them. At the launch event in Kampala, UNAIDS Executive Director Winnie Byanyima gave a keynote address in support of the Manifesto’s call for all stakeholders to commit to the budgets and strategies that will make choice possible.
“I congratulate you for the HIV Prevention Choice Manifesto. It’s about pushing everyone towards people-centered, women-centered and women-led approaches to HIV prevention. You have fought with your lives to get here. You are fearless feminists. Women must lead for themselves.” – Winnie Byanyima, UNAIDS Executive Director
The DPP Consortium created a multiyear strategy to frame priorities and next steps in the development and delivery of the dual prevention pill (DPP), which is being developed to prevent HIV and unintended pregnancy. This multipurpose prevention technology (MPT) combines oral PrEP with an oral contraceptive. The updated strategy consolidates two years of progress toward preparing the field for new MPTs. The strategy addresses additions to the MPT pipeline, the potential role of the private sector in delivering a future DPP, recommendations for provider counseling on the use of the DPP, market research on potential DPP users, the latest analysis on cost, and more.
Stay tuned for more resources and updates to come on the DPP, the Choice Manifesto, and tools for connecting choice to HIV prevention, ending the epidemic and the role of choice in global health equity in HIV, and beyond.
HIV Prevention Choice Manifesto
The HIV Prevention Choice Manifesto emphasizes community-led leadership and the importance of choice in HIV prevention for African women and girls. The manifesto advocates for universal access to a broad range of biomedical tools for HIV prevention and underscores the transformative potential when African women and girls lead advocacy and response efforts in HIV healthcare.
PEPFAR is one of the greatest US foreign policy and global development achievements of the century. The program has saved upwards of 25 million lives since it launched in 2003. But as PEPFAR marks its 20th anniversary, it’s also fighting for its future.
The US Congress needs to reauthorize PEPFAR for another five years by September 30 and reaffirm its commitment to this lifesaving program. Until a couple of months ago, most in global health and development expected smooth sailing for a five-year reauthorization of the program, as has happened throughout the past 20 years. PEPFAR has enjoyed deep and broad bipartisan support since its founding. Evangelical Christians, staunch conservatives and progressive liberals, Democrats and Republicans, HIV activists, civil society advocates and public health leaders have all championed PEPFAR, year in and year out. But a handful of Republicans, including past PEPFAR allies, are pulling reauthorization into high-stakes partisan politics.
In this episode, Px Pulsetalks to some of the people who put PEPFAR dollars into action and to global health leaders who explain why PEPFAR’s approach has been so effective, and what’s at stake in this debate.
Tune in to hear:
Ilda Kuleba from Mothers 2 Mothers talks about the impact of PEPFAR on their work across 10 countries, training and employing HIV positive mothers as peer healthcare workers.
Dr. James Mukabi of World Vision’s Kenya program talks about how this Christian relief organization has changed the lives of thousands of orphans and other populations who are vulnerable to HIV.
Tom Hart, President of the ONE Campaign, which was co-founded by the rock star Bono, to be an early champion of PEPFAR and other poverty fighting efforts talks about PEPFAR’s accomplishments at the global level and what’s next as Congress debates reauthorizing the program.
PEPFAR’s supporters have a job to do, to make sure everyone understands that the world has a lot to lose if PEPFAR is weakened and so, so much to gain if US policymakers unite in their support. We hope you will listen and pass on the episode, download the resources and, most especially, add your voice in support of PEPFAR.
The updated AVAC.org also reflects the expanded vision and practice of our dynamic programs. AVAC will always work to accelerate ethical development and equitable delivery of effective HIV prevention options. But, we also know that responding to HIV and preparing for future pandemics requires a comprehensive, integrated, and sustained response that is rights-based, people-centered and evidence-informed.
To AVAC, this means connecting the dots between HIV prevention, sexual and reproductive health and rights, pandemic preparedness, strengthened health systems, research engagement and community leadership. It means recognizing that resilience in global health requires us to confront the threats posed by disparities in access, entrenched stigma, discrimination, criminalizing key populations and inadequate responses to other sexually transmitted infections.
Visit the new AVAC.org for resources, tools and analysis that make these connections as we continue to track and translate the field, including:
Information on the entire pipeline of biomedical prevention strategies being investigated today
Our projects, which showcase the incredible partnerships and collaboration that underpin everything we do
Our podcast, PxPulse, which will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead
PxWire our quarterly update on where we are in biomedical prevention research
Our HIV clinical trials database, where you can find details on all biomedical prevention trials and our broader resource database containing fact sheets, infographics, blog posts and more on HIV prevention and the broader issues surrounding global health equity
We are immensely proud to share these resources with you. We hope these tools and analyses will help to power your advocacy, accelerate ethical development and equitable delivery of effective HIV prevention options, and advance global health equity.
How do People Who Use/Inject Drugs Intersect with PrEP Research and Service Delivery?
On Wednesday, September 6, The Choice Agenda (TCA), the International Network of People Who Use Drugs (INPUD) and our wonderful expert speakers discussed the health and wellness priorities of people who use/inject drugs, and how these communities (“key populations”) intersect across PrEP research, development, and implementation activities. They highlighted critical gaps in the PrEP agenda, underscore opportunities for improvement, and share strategies for better inclusion, representation and meaningful engagement.
Speakers: John Kimani, Kenya Network of People Who Use Drugs (KeNPUD) Dr. Sunil Solomon, Johns Hopkins University, Dr. Tetiana Kaleeva
** With special thanks to WHO, this webinarwill offer simultaneous Ukrainian translation.**
Achieving successful HIV prevention relies on programs and research shaped by communities and grounded by their needs and priorities. Skilled and informed community advocates drive this process. AVAC’s Advocacy Fellows Program expands and strengthens the capacity of civil society advocates and organizations to monitor, support and help shape HIV prevention research and rapid rollout of new effective interventions in low- and middle-income countries facing substantial HIV burdens.
The program provides intensive support to emerging and mid-career advocates to execute advocacy projects addressing locally identified gaps and priorities. Fellows receive comprehensive training, financial backing, and technical assistance to strategize and execute a targeted 18-month project hosted by an organization within their country.
In its 15-year history, 85 Fellows and 75 partner organizations across 15 countries have participated in the program. They have influenced policy, championed community perspectives, strengthened healthcare systems, demystified HIV prevention research, advocated for fairness and transparency on local, regional, and global scales and now lead many national and regional organizations. Discover more about the program’s impact here. As the 2022 Fellows conclude their Fellowships, learn more about their projects and achievements here.
What’s New in 2024
While HIV biomedical prevention advocacy remains central, we encourage projects with a strong focus on health equity, structural considerations, and links to TB, STIs, and sexual and reproductive health and rights. Advocacy projects related to pandemic prevention, preparedness and response are also welcomed.
Eligibility
Emerging or mid-career community leaders and advocates who want to advance their advocacy skills and advocate for HIV, SRHR, STI, TB, and pandemic prevention and preparedness.
Individuals with experience or education in HIV or public health, or in advocacy for key populations (e.g., sex workers, LGBTQIA+ individuals, pregnant individuals, people who use drugs) or for social and economic justice.
Based in low- and middle-income countries with substantial HIV burdens and ongoing HIV prevention research or introduction of new interventions.
Please note that for 2024 fellowships, priority focus lies in Eastern and Southern Africa.
Applications are due by 2 October 2023, and 2024 Fellowships will run from April 2024 through September 2025.
Spread the Word
Help us reach potential advocates by sharing this information within your networks.
We look forward to receiving your application and making a positive impact together.
AVAC Advocacy Fellows Program 2024-2025 Application Social Media Tile
The AVAC Advocacy Fellows Program is now recruiting its 13th class and is looking for the next cohort of emerging and mid-career advocates to explore what’s needed to address epidemics and progress global public health equity.
Want to help spread the word? Download our shareable social media tile.